ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 라임병 검사 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 연평균 복합 성장률(CAGR) 9.1%로 확대되어 151억 1,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 라임병 유행지로의 항해 증가, 멀티플렉스 진단 기술의 이용 증가, 옥외 레크리에이션 활동 급증, 가정용 검사 키트 수요 증가, 다른 진드기 매개 질환과의 병발에 대한 우려 증가 등에 기인한다고 생각됩니다. 예측기간에 예상되는 주요 동향으로는 분자진단법의 진보, 바이오마커 탐색의 진전, 포인트 오브 케어 검사기기의 기술 혁신, 랩온칩(마이크로유체) 플랫폼의 개발, 면역측정기술의 향상 등을 들 수 있습니다.
진드기 매개 질환의 만연 증가는 라임병 검사 시장의 성장을 가속할 것으로 예측됩니다. 진드기 매개 질환은 감염된 진드기에 물린 것에 의해 인간에게 감염되는 질환이며, 진드기는 수풀이나 삼림지대, 농촌지대에서 자주 보이는 소형의 기생충입니다. 진드기 매개 질환에 대한 치료 및 검사에 대한 수요는 기후 변화의 영향으로 인해 진드기의 지리적 분포가 확대됨에 따라 노출률과 감염률이 증가함에 따라 증가하고 있습니다. 진드기는 라임병의 주요 매개 동물이기 때문에 이러한 질병 증가는 조기 발견과 정확한 진단의 필요성을 돋보이게합니다. 예를 들어 미국을 거점으로 하는 연방공중위생기관인 질병대책예방센터(CDC)는 2024년 7월, 진드기가 매개하는 감염증의 증례 수가 2021년 36,177건에서 2022년에는 71,346례로 증가했다고 보고하고 있습니다. 그 결과 진드기 매개 질환의 증례 수 증가가 라임병 검사 수요를 촉진하고 있습니다.
라임병 검사 시장의 기업은 검사 정밀도 향상, 소요 시간 단축, 질병 조기 발견을 지원하는 진단 도구의 혁신을 중시하고 있습니다. 이러한 진단 도구에는 라임병의 원인균인 보렐리아 버그도르페리와 관련된 항체, 항원, 유전 물질을 검출하여 라임병의 존재를 확인하도록 설계된 장치, 키트, 기술이 포함됩니다. 예를 들어, 2024년 8월 영국의 생명 공학 회사인 EpitogenX Ltd.는 새로운 라임병 진단 키트를 출시했습니다. 이 ELISA 기반 분석은 회사 고유의 EpitoGen 플랫폼을 사용하여 개발되었으며, 약 120개의 다른 보렐리아 에피토프를 포함하여 높은 특이성과 감도를 제공합니다. 연구용으로 설계된 이 키트는 조기 균주 특이적 검출을 가능하게 하고, 다양한 검사 환경에 적응할 수 있어 진단 정밀도의 향상과 라임병에 대한 보다 깊은 통찰력을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 라임병 검사 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 라임병 검사 시장 : 성장률 분석
세계의 라임병 검사 시장 실적 : 규모와 성장, 2019-2024
세계의 라임병 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 라임병 검사 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 라임병 검사 시장 : 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
혈청학적 검사
핵산 검사
소변 항원 검사
기타 검사 유형
세계의 라임병 검사 시장 : 검사 조사 방법, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
효소 면역 측정(ELISA)
웨스턴 블롯
중합효소 연쇄반응(PCR)
면역형광측정법(IFA)
기타 신기술
세계의 라임병 검사 시장 : 질환 단계별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
초기 라임병
파종성 라임병
만성 라임병
무증상 라임병 검출
세계의 라임병 검사 시장 : 샘플 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
피
소변
뇌척수액(CSF)
기타 혈액 샘플
세계의 라임병 검사 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원 및 진료소
진단실험실
재택 케어 환경
연구기관
공중위생기관
세계의 라임병 검사 시장 : 혈청학적 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
효소 면역 측정법
웨스턴 블롯
면역형광측정법(IFA)
라인 면역 검정(LIA)
세계의 라임병 검사 시장 : 핵산 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
중합효소 연쇄반응(PCR)
루프 개재 등온 증폭(LAMP)
차세대 시퀀싱(NGS)
세계의 라임병 검사 시장 : 소변 항원 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
래터럴 플로우 분석
효소 면역 측정(EIA)
면역 블롯 소변검사
세계의 라임병 검사 시장 : 기타 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
배지 기반 시험
진드기 매개 중복 감염 패널
인공지능 지원 진단 도구
제7장 지역별/국가별 분석
세계의 라임병 검사 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 라임병 검사 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
라임병 검사 시장 :경쟁 구도
라임병 검사 시장 : 기업 프로파일
Roche Holding AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Labcorp Holdings Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Quest Diagnostics Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
Eurofins Scientific : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
BIOMERIEUX
Quidel Corporation
Bio-Rad Laboratories Inc.
QIAGEN NV
DiaSorin SpA
Meridian Bioscience
Everlywell
Trinity Biotech
T2 Biosystems
IGeneX
Viramed Biotech AG
Ceres Nanosciences
Galaxy Diagnostics
Novatein Biosciences
Lyme Diagnostics Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
라임병 검사 시장(2029년) : 새로운 기회를 제공하는 국가
라임병 검사 시장(2029년) : 새로운 기회를 제공하는 부문
라임병 검사 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Lyme disease testing involves diagnostic methods used to identify infection with Borrelia burgdorferi, the bacterium responsible for Lyme disease, which is commonly transmitted via tick bites. The primary goal of Lyme disease testing is to ensure accurate diagnosis, particularly in individuals presenting symptoms such as fever, fatigue, and the distinctive bull's-eye rash.
The primary types of tests used in Lyme disease diagnostics include serological tests, nucleic acid tests, urine antigen tests, and others. Serological tests detect the presence of antibodies or antigens in a patient's blood to determine exposure to infections or immune responses. Common testing techniques include enzyme-linked immunosorbent assay (ELISA), Western blot, polymerase chain reaction (PCR), immunofluorescence assay (IFA), and others. Testing is applicable across different disease stages, including early Lyme disease, disseminated Lyme disease, chronic Lyme disease, and asymptomatic infection detection. Various sample types used include blood, urine, cerebrospinal fluid (CSF), and more. These diagnostic procedures are carried out by a range of end users, such as hospitals and clinics, diagnostic laboratories, home care settings, research institutions, and public health agencies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The lyme disease testing market research report is one of a series of new reports from The Business Research Company that provides lyme disease testing market statistics, including lyme disease testing industry global market size, regional shares, competitors with a lyme disease testing market share, detailed lyme disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the lyme disease testing industry. The lyme disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The lyme disease testing market size has grown strongly in recent years. It will grow from $9.77 billion in 2024 to $10.68 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be attributed to the rising demand for early disease diagnosis, increased accessibility to advanced diagnostic technologies, a growing tick population driven by climate change, enhanced government funding for the control of vector-borne diseases, and the expansion of healthcare infrastructure in rural and endemic regions.
The lyme disease testing market size is expected to see strong growth in the next few years. It will grow to $15.11 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth during the forecast period can be attributed to the rising travel to Lyme-endemic areas, increased utilization of multiplex diagnostic technologies, a surge in outdoor recreational activities, growing demand for at-home testing kits, and heightened concerns about co-infections with other tick-borne illnesses. Key trends expected in the forecast period include progress in molecular diagnostic methods, advancements in biomarker discovery, technological innovations in point-of-care testing devices, developments in lab-on-a-chip (microfluidic) platforms, and improvements in immunoassay technologies.
The increasing prevalence of tick-borne illnesses is expected to drive the growth of the Lyme disease testing market. Tick-borne illnesses are diseases transmitted to humans through bites from infected ticks, which are small parasites commonly found in grassy, wooded, or rural areas. The demand for treatments and testing related to tick-borne illnesses is rising due to the expanding geographic distribution of ticks, largely influenced by climate change, resulting in greater exposure and infection rates. Since ticks are the primary vectors for Lyme disease, the increase in these illnesses highlights the need for early detection and accurate diagnosis. For example, in July 2024, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported 71,346 cases of tick-borne diseases in 2022-up from 36,177 cases in 2021. As a result, the growing number of tick-borne illness cases is fueling the demand for Lyme disease testing.
Companies in the Lyme disease testing market are emphasizing technological innovations in diagnostic tools to improve test accuracy, decrease turnaround times, and support early-stage disease detection. These diagnostic tools include devices, kits, and technologies designed to identify the presence of Lyme disease by detecting antibodies, antigens, or genetic material associated with Borrelia burgdorferi, the bacteria responsible for the disease. For instance, in August 2024, EpitogenX Ltd., a UK-based biotechnology company, launched a new Lyme Disease Diagnostic Kit. This ELISA-based assay was developed using the company's proprietary EpitoGen platform and includes approximately 120 distinct Borrelia epitopes, offering high specificity and sensitivity. Designed for research use only (RUO), the kit enables early, strain-specific detection and can be adapted for various laboratory settings, providing enhanced diagnostic accuracy and deeper insights into Lyme disease.
In May 2024, T2 Biosystems Inc., a US-based in vitro diagnostics company, formed a partnership with ECO Laboratory to improve early Lyme disease detection. This collaboration focuses on advancing the development and clinical validation of the T2Lyme Panel, a molecular diagnostic test aimed at providing accurate and early detection of Lyme disease. The partnership utilizes ECO Laboratory's CLIA-certified facilities to broaden access to advanced tick-borne disease testing throughout the United States. ECO Laboratory is a US-based diagnostic service provider specializing in Lyme and other tick-borne illnesses.
Major players in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMERIEUX, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Everlywell, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Novatein Biosciences, and Lyme Diagnostics Ltd.
North America was the largest region in the lyme disease testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lyme disease testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the lyme disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lyme disease testing market includes revenues earned by entities by providing services such as diagnostic test kit development, laboratory testing services, polymerase chain reaction (PCR)-based testing, serological testing, and point-of-care testing solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lyme Disease Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lyme disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lyme disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lyme disease testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Test Type: Serological Tests; Nucleic Acid Tests; Urine Antigen Tests; Other Test Types
2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA); Weste Blot; Polymerase Chain Reaction (PCR); Immunofluorescence Assay (IFA); Other Emerging Technologies
3) By Disease Stage: Early Lyme Disease; Disseminated Lyme Disease; Chronic Lyme Disease; Asymptomatic Lyme Disease Detection
4) By Sample Type: Blood; Urine; Cerebrospinal Fluid(CSF); Other Blood Samples
5) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Home Care Settings; Research Institutions; Public Health Organizations
Subsegments:
1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lyme Disease Testing Market Characteristics
3. Lyme Disease Testing Market Trends And Strategies
4. Lyme Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Lyme Disease Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Lyme Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Lyme Disease Testing Market Growth Rate Analysis
5.4. Global Lyme Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Lyme Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Lyme Disease Testing Total Addressable Market (TAM)
6. Lyme Disease Testing Market Segmentation
6.1. Global Lyme Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serological Tests
Nucleic Acid Tests
Urine Antigen Tests
Other Test Types
6.2. Global Lyme Disease Testing Market, Segmentation By Testing Methodology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay (ELISA)
Weste Blot
Polymerase Chain Reaction (PCR)
Immunofluorescence Assay (IFA)
Other Emerging Technologies
6.3. Global Lyme Disease Testing Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Early Lyme Disease
Disseminated Lyme Disease
Chronic Lyme Disease
Asymptomatic Lyme Disease Detection
6.4. Global Lyme Disease Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood
Urine
Cerebrospinal Fluid(CSF)
Other Blood Samples
6.5. Global Lyme Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Home Care Settings
Research Institutions
Public Health Organizations
6.6. Global Lyme Disease Testing Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay
Western Blot
Immunofluorescence Assay (IFA)
Line Immunoassay (LIA)
6.7. Global Lyme Disease Testing Market, Sub-Segmentation Of Nucleic Acid Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR)
Loop-Mediated Isothermal Amplification (LAMP)
Next-Generation Sequencing (NGS)
6.8. Global Lyme Disease Testing Market, Sub-Segmentation Of Urine Antigen Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lateral Flow Assay
Enzyme Immunoassay (EIA)
Immunoblot Urine Tests
6.9. Global Lyme Disease Testing Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Culture-Based Tests
Tick-Borne Co-Infection Panels
Artificial Intelligence-Assisted Diagnostic Tools
7. Lyme Disease Testing Market Regional And Country Analysis
7.1. Global Lyme Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Lyme Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
